Hdl in sepsis – risk factor and therapeutic approach

HIGHLIGHTS

• who: Xiang-An Li and Anna Schwendeman from the Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, MI, USA, Biointerfaces have published the article: HDL in sepsis - risk factor and therapeutic approach, in the Journal: CSL-111 ApoA1:Soy PC (1:150 mol/mol) rHDL
• what: Given these clinical and experimental data, the authors propose that low HDL is a risk factor for sepsis and that targeting HDL may provide an efficient and effective therapy for sepsis.

SUMMARY

Sepsis is a major health issue in the U . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or E-mail:

If you don't have an account, you can create one here.